Daniel Ma
@DanielMaMD
Enterprise Head & Neck Disease Group Chair @MayoCancerCare. Head & Neck Division Chair @MayoRadOnc.
DART 2, which was based upon this work, should finish accrual Q2 2026, so more data on ctDNA-personalized de-escalation will be available in the near future. Primary manuscript for DART should be out in the next two months as well.
This is very nice work and has important implications for the use of NavDX (ctHPVDNA by ddPCR) to determine postoperative treatment. During the Mayo DART trial, ctDNA was drawn a median of 22 days after surgery, with 17/140 (12.1%) positive. ALL of these patients then received…
🌺Join us in Kauai for a dynamic #RadOnc CME experience featuring expert insights, engaging panels, & incredible views. Hear from @KimCorbinMD, @allisongardaMD, @aadel_chaudhuri, @SameerKeoleMD & @DanielMaMD, along with other experts from @MayoRadOnc. mayocl.in/4e2zock
great work Dr Routman and team @MayoRadOnc
.@DavidRoutmanMD presented an investigator-initiated study on the use of a therapeutic vaccine alone or combined with pembrolizumab in #HPV-associated oropharyngeal carcinoma. This novel therapy is directed at HPV E6 & E7 and was delivered prior to surgery or radiation. #ASCO25
The MN delegation for @ASTRO_org Advocacy Day joined with diverse rad oncs from multiple states to champion NIH/NCI funding, prior auth reform, and support for ROCR. Hopeful and optimistic that we can preserve cancer research and #radonc for future generations. #ASTROAdvocacy




Humbled and happy as well that @MayoCancerCare was a part of this important work as well! @DavidRoutmanMD @KatieVanAbelMD
Very humbled to be involved in this work with a whole suit of experts on this disease. Continuation of our TNM work in #Nasopharyngealcarcinoma #Headneckcancer @DanielMaMD
Very humbled to be involved in this work with a whole suit of experts on this disease. Continuation of our TNM work in #Nasopharyngealcarcinoma #Headneckcancer @DanielMaMD
Reclassifying each N category 1 stratum higher for imaging-detected extranodal extension-positive disease resulted in better disease-free and overall survival in patients human papillomavirus–positive oropharyngeal carcinoma. ja.ma/4k0TANm @DrMLChua
The Head and Neck Division @MayoRadOnc is excited to announce that @ryanjbrisson from @UFRadOnc will be joining our staff in the fall. Welcome to the team!

Very happy to host @henson_md on behalf of @MayoRadOnc as a visiting professor! Loved her insightful thoughts on being an investigator with @NRGonc and her great talk on career development.



🎉Happy #ThankAResidentDay! 🎉 To #Radonc residents everywhere (especially @MayoRadOnc) your dedication, compassion, and brilliance are inspirational! From patient care 💙 to education & research 📚—you do it all! THANK YOU for making our program and specialty stronger. 💪✨
Register for the Mayo Clinic Multidisciplinary Head & Neck Cancer Symposium March 27-29 in AZ or via livestream. Topics will include the latest in #HeadAndNeckCancer care including surgical, radiation and medical oncology and symptom control/survivorship: mayocl.in/3EtLVHS
This may not be "practice-changing" per se but kudos to the investigators for running this trial. I have known Prof Tang for many years now and she is a solid clinician who has prob treated more #NPC than most of us (even experts) around the world! Look out for more…
Happy that my aurora photo made the cover of @IJROBP ! redjournal.org/content/cover1…


Fantastic editorial by @NEJM titled, “Treating Patients, Not P Values.” eviden.cc/3OYutgJ
Tremendous work by my good friend and @UTSWENT colleague Dr. Andrew Day to discuss the impact of RT on carotid artery stenosis and the implications for screening. TL/DR: lots of work to do!
New editorial from @UTSWMedCenter investigators | Considerations in screening for asymptomatic carotid artery stenosis in irradiated head and neck cancer survivors acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert #HNCSM
Finalizing the @ABR_Radiology HN oral exam with a wonderful group of dedicated individuals. Honored to be part of this group.

Mayo Clinic Rochester is recruiting a Head and Neck Radiation Oncologist. We are a collaborative, multi-disciplinary group passionate about novel treatment techniques, clinical trials, and translational research. Come take a look! jobs.mayoclinic.org/job/rochester/… #radonc #hncsm
Welcome to join our educational session on Linear Energy Transfer (LET) and Relative Biological Effectiveness (RBE) in Proton Therapy - Controversies and Gaps in Knowledge if you are attending ASTRO 2024. #cancerresearch #protontherapy #let #rbe